Earlier works reported that VEGFA could drive cancer-initiating stem cells in triple-negative breast cancer and non-small cell lung carcinoma, primarily through the myc/stat3/sox2 axis [17,18]. This evidence concerns the gene MYC and non-small cell lung carcinoma.